Transaction in Own Shares

Fidelity Emerging Markets Limited repurchased and cancelled 29,232 ordinary shares on 18 December 2025 at an average price of 1,008.49 GBp (low 1,006.00 GBp; high 1,010.00 GBp). Following the transaction issued share capital is 53,764,693, total shares held in treasury 9,025,940 and total voting rights 44,738,754, representing a de minimis reduction in outstanding shares and a modest shareholder-return action unlikely to materially move the stock.

Analysis

Market structure: The buyback is economically tiny (29,232 shares ≈ 0.054% of issued capital) but strategically meaningful because the trust already holds 9,025,940 shares in treasury (~16.8% of issued). Direct winners are continuing shareholders (modest NAV/share uplift and signalling of undervaluation); losers are marginal (cash reduction, reduced float/liquidity). Cross-asset effects are negligible for FX, bonds and commodities; only relative pricing vs EM ETFs (EEM/VWO) and option-implied volatility could move marginally on re‑rating.

Risk assessment: Tail risks include an EM liquidity shock that widens the trust’s discount to NAV, a UK regulatory/tax change limiting buybacks, or manager behavior that sacrifices AUM/fees (repeated cancellations reduce fee base). Immediate impact (days) is likely a small positive price blip; short term (weeks–months) depends on NAV prints and further buyback cadence; long term (quarters) the materiality hinges on whether treasury holdings are further cancelled — a 5–10% additional cancellation would be meaningful.

Trade implications: Best direct play is a small, conditional long in Fidelity Emerging Markets Ltd (London-listed EM trust) to capture discount-narrowing with a hedge of broad EM beta (short EEM/VWO). Use 3–6 month horizons: enter if discount >7%, target re-rating to <3% or +15–25% total return, stop-loss −8% absolute or if discount widens >5ppt. Options: prefer call-spread overlays on EEM to cap cost if liquidity in the trust is thin.

Contrarian angles: Market treats this repurchase as token; investors often underweight cumulative treasury size — 16.8% suggests management has executed substantial buybacks already and can continue, creating asymmetric upside if buybacks accelerate. Risks underappreciated: lower secondary liquidity and potential downward pressure on manager fees; watch for board buyback programme size announcements over next 30–90 days as the catalyst for re‑rating.

Key Decisions for Investors

• Establish a 1–2% portfolio long position in Fidelity Emerging Markets Limited (London-listed EM trust) only if the discount to NAV is >7%; horizon 6–12 months, target exit when discount narrows to <3% or price +15–25%, stop-loss at −8% absolute or if discount widens by >5 percentage points.
• Hedge market risk by shorting iShares MSCI Emerging Markets ETF (EEM) sized to ~0.6x the notional of the trust long (to neutralize ~60% beta); maintain the hedge for 3–6 months and rebalance monthly against NAV moves.
• If preferring limited risk, buy a 3–6 month call spread on EEM (buy ~2% OTM, sell ~8% OTM) sized to replicate upside exposure at ~25–40% cheaper cost versus outright long; enter when the trust announces further buyback authority or NAV stability over two consecutive monthly prints.
• Reduce passive EM ETF exposure (EEM/VWO) by 1–3% in favor of active closed‑end trusts with demonstrable buyback history; redeploy once trust announces a formal, larger buyback programme or treasury cancellation plan within the next 30–90 days.